Trump Submits Saudi Nuclear Deal to Congress Amid Normalization Deadlock

Key Facts

In a move reflecting the U.S. administration's efforts to strengthen strategic energy partnerships in the Middle East, President Donald Trump has formally submitted the civilian nuclear cooperation agreement with Saudi Arabia to Congress. This submission triggers a mandatory 90-legislative-day review period for the 30-year pact, which is designed to allow U.S. companies to export civilian nuclear technology to the Kingdom. According to reports, this procedural step comes at a sensitive time characterized by political maneuvering over the conditions required for the deal's final activation.

The agreement faces a significant diplomatic hurdle as President Trump has conditioned the deal's implementation on the normalization of ties with Israel, a requirement Riyadh has explicitly rejected. Saudi Arabia reiterated its stance that no normalization will occur without the establishment of an independent Palestinian state. The proposed deal seeks to position U.S. firms to build Saudi Arabia's nuclear infrastructure over international competitors, while leaving open the possibility of domestic uranium enrichment under strict U.S. oversight to ensure civilian compliance.

Given that current price data for related instruments is unavailable at this time, investors are closely monitoring the outcome of the congressional review in Washington as a future catalyst. With no major upcoming economic events directly related to this file in the immediate calendar, geopolitical developments remain the primary driver of market expectations. The stance taken by Congress over the next 90 days, and the administration's ability to navigate the deadlock over normalization conditions, will be decisive for the fate of this long-term nuclear cooperation.